News Aug 03, 2023 Worg secures financing of 130 million Swiss francs The Chinese biopharmaceutical firm Worg Pharma, whose European headquarters are located in the Basel Area, has secured gross proceeds equivalent ...
Spotlight Jun 15, 2023 Access to Ecosystem Switzerland is a global leader in biotech, medtech and pharma. Find out what makes the Swiss life science industry unique and how your life scien...
News Dec 16, 2021 Basel alliance seeks to combat antibiotic resistance The SPEARHEAD alliance has been founded in Basel with the aim of combating the silent pandemic of antimicrobial resistance. By 2050, this will ca...
News Jul 13, 2021 Merck reaches key milestone in the construction of its Biotech Development Center Merck has celebrated the completion of the structural work on its Biotech Development Center currently under construction in Corsier-sur-Vevey.
News Mar 08, 2021 Debiopharm enters EUR 900+ million contract with Merck Debiopharm has granted a worldwide exclusive license to pharma giant Merck for the development and commercialization of its Xevinapant head and n...
S-GE Event Tomorrow's Health: Meet the Experts on Patient Data, Empowerment & Blockchain Jun 17, 2021 Jun 17, 2021 Switzerland
Инвестиции в Швейцарии Ваши контакты за рубежом Представительства S-GE за рубежом называются «Швейцарские Центры содействия бизнесу» (Swiss Business Hubs).
News May 11, 2021 EPFL spin-off bNovate expands globally after raising CHF 5 million With its connected solutions allowing bacteria measurement in water in only 20 minutes, industrial microbiology specialist bNovate Technologies h...
S-GE Event Tomorrow's Health: Meet the Experts on Diagnostics and AI Jun 17, 2021 Jun 17, 2021 Switzerland
Investir na Suíça Promoção de Investimentos Internacionais na Suíça Os escritórios de representação da S-GE no exterior recebem o nome de Swiss Business Hubs (SBH).
News Jan 26, 2021 Opterion Health AG moving to Muttenz Opterion is moving from the canton of Obwalden to Muttenz in the canton of Basel-Landschaft in order to benefit from the local life sciences ecos...
News Apr 13, 2021 Lonza to create 1,200 new jobs at its Covid-19 vaccine production site in Visp Biopharmaceutical giant Lonza has announced the creation of 1,200 new jobs for the manufacturing of Moderna’s Covid-19 vaccine on its site in Vis...
Press Release Jan 30, 2024 Exports stagnant: Swiss companies adjust their expectations and strategies Swiss SMEs are still expecting minimal export growth in the coming months. This is the finding of the latest survey of Swiss SMEs conducted by Sw...
Invertir en Suiza Fomento de la inversión en el extranjero Las representaciones de S-GE en el extranjero se denominan Swiss Business Hubs (SBH).